Nostrumlabs: Nostrum Laboratories recalls Type 2 diabetes drug over contamination problems

Nostrum Laboratories is initiating the voluntary recall of two lots of its Metformin HCI extended-release tablets for people with diabetes. According to an FDA news release, the Metformin HCI extended-release tablets (USP 750mg) were found to contain levels of nitrosamine impurities above the ADI limit of 96ng per day, as stipulated in the FDA Guidance Document... The post Nostrum Laboratories recalls Type 2 diabetes drug over contamination problems appeared first on Pharmaceutical Processing World.